Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03865602 · ClinicalTrials.gov registry record · NA
Improving Morbidity During Post-Acute Care Transitions for Sepsis
A NA study of Clinical Sepsis, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 712
- Enrollment target
- 1
- Study location
NCT03865602 is a NA study of Clinical Sepsis that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 712 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03865602, a NA study of Clinical Sepsis, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 712 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to improve transitions of care for the highest risk, complex patients with suspected sepsis. Atrium Health has developed a nurse-navigator facilitated care transition strategy, called the Sepsis Transition and Recovery (STAR) program, to improve the implementation of recommended care practices and bridge care gaps for patients in the post-sepsis transition period. During their hospitalization, STAR program patients enter into a transition pathway facilitated by a centrally located nurse navigator and including the following evidence-based post-sepsis care components: i) review and recommendation for adjustment of medications; ii) identification of and referral for new physical, mental, and cognitive deficits; iii) surveillance for treatable conditions that commonly lead to poor outcomes; and iv) referral to palliative care when appropriate. IMPACTS (Improving Morbidity during Post-Acute Care Transitions for Sepsis) is a pragmatic, randomized program evaluation to compare clinical outcomes between sepsis survivors who receive usual care versus care delivered through the STAR program following hospitalization. IMPACTS will test the hypothesis that patients that receive care through STAR will have decreased composite all cause, 30-day hospital readmission and mortality compared to patients that receive usual care.
Conditions Studied
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL Sepsis Transition And Recovery (STAR)
Study Locations (1)
North Carolina
- Atrium Health - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 712 participants |
| Start Date | 2019-01-29 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03865602
The ClinicalTrials.gov registry entry for NCT03865602 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 712 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Clinical Sepsis appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT03865602 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03865602 about?
NCT03865602 is a clinical study titled "Improving Morbidity During Post-Acute Care Transitions for Sepsis". The purpose of this study is to improve transitions of care for the highest risk, complex patients with suspected sepsis. Atrium Health has developed a nurse-navigator facilitated care transition strategy, called the Sepsis Transition and Recovery (STAR) program, to improve the implementation of rec...
What is the current status of trial NCT03865602?
This trial is currently completed. It is a NA study. The enrollment target is 712 participants. The study started on 2019-01-29. Estimated completion is 2021-12-31.
What conditions does trial NCT03865602 study?
This clinical trial studies the following conditions: Clinical Sepsis.
What interventions are being tested in trial NCT03865602?
The interventions under investigation include: Usual care (BEHAVIORAL), Sepsis Transition And Recovery (STAR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03865602?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03865602 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.